吉利德签署lenacapavir使用权协议;Arvinas首席执行官将卸任Gilead signs lenacapavir access deal; Arvinas CEO to step down

动脉网
09 Jul

Today, a brief rundown of news involving Gilead Sciences and Arvinas, as well as updates from Chugai Pharmaceutical, Recursion Pharmaceuticals and Dizal Pharma that you may have missed.今天,简要介绍您可能错过的涉及...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10